financetom
Business
financetom
/
Business
/
Amazon down for over 6,000 users in US, Downdetector says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amazon down for over 6,000 users in US, Downdetector says
Nov 5, 2025 4:03 PM

Nov 5 (Reuters) - Amazon.com ( AMZN ) was down for 6,250

of users in the U.S. on Wednesday, outage tracking website

Downdetector.com said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CVS Health's Aetna Gets Michigan Recommendation for Dual Eligible Special Needs Plan Contract
CVS Health's Aetna Gets Michigan Recommendation for Dual Eligible Special Needs Plan Contract
Oct 11, 2024
01:42 PM EDT, 10/11/2024 (MT Newswires) -- CVS Health's ( CVS ) Aetna unit said Friday that the state of Michigan recommended the company for a new dual eligible special needs plans contract. Pending the end of a protest period and readiness review by the state, Aetna said the new contract is slated to start on Jan. 1, 2026 and...
CIBC's Week Ahead Market Call For Canada
CIBC's Week Ahead Market Call For Canada
Oct 11, 2024
01:45 PM EDT, 10/11/2024 (MT Newswires) -- CIBC's Ali Jaffery and Katherine Judge noted Tuesday's CPI data will be the final piece of major information that the Bank of Canada receives on the economy ahead of the October meeting. The CIBC duo said headline inflation is expected to dip below target and look even more muted excluding mortgage interest costs....
Pfizer Gets FDA Approval for Hemophilia A, B Treatment
Pfizer Gets FDA Approval for Hemophilia A, B Treatment
Oct 11, 2024
01:44 PM EDT, 10/11/2024 (MT Newswires) -- Pfizer ( PFE ) said Friday that the US Food and Drug Administration approved Hympavzi to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B without certain inhibitors. The drug is approved for adults and pediatric patients 12 years or older, according to the company. The approval...
CeriBell Shares Soar in Nasdaq Debut
CeriBell Shares Soar in Nasdaq Debut
Oct 11, 2024
01:33 PM EDT, 10/11/2024 (MT Newswires) -- CeriBell (CBLL) shares soared in recent Friday trading after the medical technology company made its debut on Nasdaq. The stock was trading up over 41% at $23.99 in afternoon trading after opening at $23.26. The company is offering about 10.6 million shares at $17 a share in the initial public offering that is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved